|
1.
|
Radiotherapy is a cancer treatment that uses high-energy X-rays to kill cancer cells. A major challenge in treating cancer is the heterogeneity of the disease. Preclinica [...]
09 May 2024 |
Biological Sciences; Mathematics; Radiation and Cellular Oncology |
Thesis |
|
|
2.
|
The proto-oncogene MYC encodes a nuclear transcription factor that has an important role in a variety of cellular processes, such as cell cycle progression, proliferation [...]
23 May 2024 |
Ben May Department for Cancer Research; Medicine; Pathology; Radiation and Cellular Oncology; Surgery |
Article |
|
|
3.
|
The use of oxygen by cells is an essential aspect of cell metabolism and a reliable indicator of viable and functional cells. Viable and functional cells are essential fo [...]
01 April 2024 |
Radiation and Cellular Oncology |
Article |
|
|
4.
|
Chemoradiotherapy combines radiotherapy with concurrent chemotherapy to potentiate antitumor activity but exacerbates toxicities and causes debilitating side effects in c [...]
21 February 2024 |
Chemistry; Radiation and Cellular Oncology |
Article |
|
|
5.
|
Importance: Clinical trials for metastatic malignant neoplasms are increasingly being extended to patients with brain metastases. Despite the preeminence of progressio [...]
26 April 2023 |
Radiation and Cellular Oncology |
Article |
|
|
6.
|
Importance: Clinical practice regarding posttreatment radiologic surveillance for patients with oropharyngeal carcinoma (OPC) is neither adapted to individual patient [...]
13 April 2022 |
Medicine; Radiation and Cellular Oncology; Radiology; Surgery |
Article |
|
|
7.
|
Importance: Postoperative chemoradiation is the standard of care for cancers with positive margins or extracapsular extension, but the benefit of chemotherapy is uncle [...]
19 November 2020 |
Medicine; Radiation and Cellular Oncology |
Article |
|
|
8.
|
Cell encapsulation represents a promising therapeutic strategy for many hormone-deficient diseases such as type 1 diabetes (T1D). However, adequate oxygenation of the enc [...]
14 May 2021 |
Radiation and Cellular Oncology |
Article |
|
|
9.
|
Cancer vaccines have been actively pursued to bolster antitumor immunity. Here, we designed nanoscale metal-organic frameworks (nMOFs) as locally activable immunotherapeu [...]
02 October 2020 |
Chemistry; Radiation and Cellular Oncology |
Article |
|
|
10.
|
RAD51 recombinase polymerizes at the site of double-strand breaks (DSBs) where it performs DSB repair. The loss of RAD51 causes extensive chromosomal breaks, leading t [...]
14 July 2011 |
Radiation and Cellular Oncology |
Article |
|
|
11.
|
These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acu [...]
02 August 2013 |
Radiation and Cellular Oncology |
Article |
|
|
12.
|
Previous reports have implicated an induction of genes in IFN/STAT1 (Interferon/STAT1) signaling in radiation resistant and prosurvival tumor phenotypes in a number of [...]
05 January 2012 |
Radiation and Cellular Oncology |
Article |
|
|
13.
|
During meiosis, repair of programmed DNA double-strand breaks (DSBs) by recombination promotes pairing of homologous chromosomes and their connection by crossovers. Tw [...]
19 December 2013 |
Human Genetics; Molecular Genetics and Cell Biology; Radiation and Cellular Oncology |
Article |
|
|
14.
|
Background: Traditionally IFN/STAT1 signaling is connected with an anti-viral response and pro-apoptotic tumor-suppressor functions. Emerging functions of a constituti [...]
08 June 2009 |
Radiation and Cellular Oncology; Surgery |
Article |
|
|
15.
|
Background: Vascular endothelial cells contribute to the pathogenesis of numerous human diseases by actively regulating the stromal inflammatory response; however, lit [...]
04 October 2012 |
Radiation and Cellular Oncology |
Article |
|
|
16.
|
Rationale: Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed [...]
10 December 2012 |
Medicine; Radiation and Cellular Oncology; Surgery |
Article |
|
|
17.
|
Background: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤5 cumulative metasta [...]
13 December 2011 |
Cancer Biology; Pathology; Radiation and Cellular Oncology; Surgery |
Article |
|
|
18.
|
Rab31 is a member of the Ras superfamily of small GTPases that has been linked to poor outcomes in patients with breast cancer. The MUC1-C oncoprotein is aberrantly ov [...]
09 July 2012 |
Radiation and Cellular Oncology |
Article |
|
|
19.
|
No abstract
02 January 2024 |
Radiation and Cellular Oncology |
Article |
|
|
20.
|
Gene expression signatures that are predictive of therapeutic response or prognosis are increasingly useful in clinical care; however, mechanistic (and intuitive) inte [...]
26 January 2012 |
Human Genetics; Medicine; Pathology; Radiation and Cellular Oncology |
Article |
|
|
21.
|
Due to the large number of putative microRNA gene targets predicted by sequence-alignment databases and the relative low accuracy of such predictions which are conduct [...]
01 April 2010 |
Human Genetics; Medicine; Pathology; Radiation and Cellular Oncology |
Article |
|
|
22.
|
Recent studies led to the proposal that meiotic gene conversion can result after transient engagement of the donor chromatid and subsequent DNA synthesis-dependent str [...]
06 November 2007 |
Human Genetics; Molecular Genetics and Cell Biology; Radiation and Cellular Oncology |
Article |
|
|
23.
|
As heavy-metal-based nanoscale metal–organic frameworks (nMOFs) are excellent radiosensitizers for radiotherapy via enhanced energy deposition and reactive oxygen speci [...]
15 August 2023 |
Chemistry; Radiation and Cellular Oncology |
Article |
|
|
24.
|
Techniques provide for passive Q switching in a bimodal resonator environment, where magnetic resonators are coupled for power transfer. A passive Q switch is responsive [...]
04 February 2020 |
Radiation and Cellular Oncology |
Patent |
|
|
25.
|
The present invention concerns methods and compositions involving inhibitors and of RAD51, a protein involved in homologous recombination. In some embodiments, there are [...]
09 February 2021 |
Radiation and Cellular Oncology |
Patent |
|
